Deals

Streamline Health Raises $12M

By |

Streamline Health Solutions (STRM) announced that it raised $12 million in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $3.00 per share, an approximate 21.47% discount to the market price ($3.82) of STRM at deal announcement. A series of 1,200,000 7-Month Warrants with an exercise price of $3.99 per share (4.45% premium) was issued to the investors in this transaction. This transaction was completed without an agent. Investors were Great Point Partners, Lyrical Opportunity Partners, and Noro-Mosleley Partners.

Deals

Talon Therapeutics in Discount Convertible Deal

By |

Talon Therapeutics (TLON) announced that it has raised $6 million in a Convertible Preferred Stock transaction. The fixed conversion price of the Convertible Preferred Stock is $0.35 per share, an approximate 61.54% discount to the market price ($0.91) of Talon at deal announcement. The Placement Agent was not disclosed, and the investors were Deerfield Management and Warburg Pincus. This Placement is the result of a Call Option exercised by the investors in a previous deal. See PlacementTracker Deal Summary.

Deals

Rodman Places BioSante Direct Offeriing

By |

BioSante Pharmaceuticals (BPAX) announced that it has raised $3.475 million in a Registered Direct transaction. The common stock was sold at $1.4725 per share, an approximate 5% discount to the market price ($1.55) of BPAX at deal announcement. A series of 1,179,966 60-Month Warrants with an exercise price of $1.50 per share (3.23% discount) was issued to the investors in this transaction. Rodman & Renshaw, LLC acted as the exclusive agent on the transaction and it is expected to close on August 21, 2012. See the PlacementTracker Deal Summary.  

Deals

Horizon Pharma in $75M ATM Transaction

By |

On August 14, 2012, Horizon Pharma, Inc. (HZNP) announced that it has secured up to $75 million in an ATM (At the Market) transaction. The purchase price is the prevailing market price at the time of the Draw Down Notice. Cowen and Company, LLC acted as the exclusive agent on the transaction. Placement Agent counsel was Goodwin Procter, LLP and issuer counsel was Cooley LLP. An agreement was reached on 08/14/2012. See PlacementTracker Deal Summary.